FI113044B - 2-hydratsinopyridiinijohdannaisia - Google Patents

2-hydratsinopyridiinijohdannaisia Download PDF

Info

Publication number
FI113044B
FI113044B FI952141A FI952141A FI113044B FI 113044 B FI113044 B FI 113044B FI 952141 A FI952141 A FI 952141A FI 952141 A FI952141 A FI 952141A FI 113044 B FI113044 B FI 113044B
Authority
FI
Finland
Prior art keywords
compound
formula
acid addition
addition salts
hours
Prior art date
Application number
FI952141A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI952141A (fi
FI952141A0 (fi
Inventor
Michael Jeffrey Abrams
Gary James Bridger
David Aaron Schwartz
Sreenivasan Padmanabhan
Michael Evert Ultee
Original Assignee
Anormed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anormed Inc filed Critical Anormed Inc
Publication of FI952141A publication Critical patent/FI952141A/fi
Publication of FI952141A0 publication Critical patent/FI952141A0/fi
Application granted granted Critical
Publication of FI113044B publication Critical patent/FI113044B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI952141A 1992-11-05 1995-05-04 2-hydratsinopyridiinijohdannaisia FI113044B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9223168 1992-11-05
GB929223168A GB9223168D0 (en) 1992-11-05 1992-11-05 Improvements in molecule labelling
GB9302259 1993-02-05
PCT/GB1993/002259 WO1994010149A1 (en) 1992-11-05 1993-11-03 Molecule labelling using 2-hydraninopyridine derivatives

Publications (3)

Publication Number Publication Date
FI952141A FI952141A (fi) 1995-05-04
FI952141A0 FI952141A0 (fi) 1995-05-04
FI113044B true FI113044B (fi) 2004-02-27

Family

ID=10724568

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952141A FI113044B (fi) 1992-11-05 1995-05-04 2-hydratsinopyridiinijohdannaisia

Country Status (19)

Country Link
US (1) US5679778A (ja)
EP (1) EP0667859B1 (ja)
JP (1) JP3542597B2 (ja)
KR (1) KR100295545B1 (ja)
AT (1) ATE195730T1 (ja)
AU (1) AU676863B2 (ja)
CA (1) CA2148595C (ja)
DE (1) DE69329293T2 (ja)
DK (1) DK0667859T3 (ja)
ES (1) ES2150950T3 (ja)
FI (1) FI113044B (ja)
GB (1) GB9223168D0 (ja)
GR (1) GR3034883T3 (ja)
HK (1) HK1013420A1 (ja)
HU (1) HU226459B1 (ja)
NO (1) NO305364B1 (ja)
NZ (1) NZ257376A (ja)
PT (1) PT667859E (ja)
WO (1) WO1994010149A1 (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5942210A (en) * 1994-11-15 1999-08-24 Cytogen Corporation Methods for lyoprotecting a macromolecule using tricine
US5919934A (en) * 1997-02-19 1999-07-06 The George Washington University Compounds, compositions, and methods for cancer imaging and therapy
PL336571A1 (en) 1997-04-30 2000-07-03 Univ Leland Stanford Junior Method of in vitro visualising the cellular death
US6403054B1 (en) 1997-05-28 2002-06-11 Bristol-Myers Squibb Pharma Company Ternary ligand complexes useful as radiopharmaceuticals
US6844333B1 (en) * 1999-03-26 2005-01-18 The Trustees Of The University Of Pennsylvania Method of treating atherosclerosis
US6686461B1 (en) 2000-03-22 2004-02-03 Solulink Bioscience, Inc. Triphosphate oligonucleotide modification reagents and uses thereof
US7102024B1 (en) 2000-08-01 2006-09-05 Schwartz David A Functional biopolymer modification reagents and uses thereof
WO2001070685A2 (en) * 2000-03-22 2001-09-27 Solulink, Incorporated Hydrazine-based and carbonyl-based bifunctional crosslinking reagents
JP2004535375A (ja) 2001-04-03 2004-11-25 テセウス イメージング コーポレーション 生体内における細胞死の検出および随伴する症状の治療のためのアネキシンの使用方法
US6726895B2 (en) 2001-04-03 2004-04-27 Board Of Trustees Of The Leland Stanford Junior University Method of imaging cell death in vivo
GB0130845D0 (en) * 2001-12-22 2002-02-06 James Peter Analysis
US7158353B2 (en) * 2003-11-06 2007-01-02 Seagate Technology Llc Magnetoresistive sensor having specular sidewall layers
WO2006052790A2 (en) * 2004-11-05 2006-05-18 The Children's Hospital Of Philadelphia Biodegradable linkers for molecular therapies
JP5886324B2 (ja) * 2011-01-31 2016-03-16 アイトゲネシッシェ テヒニッシェ ホーホシューレ チューリッヒＥｉｄｇｅｎｏｅｓｓｉｓｃｈｅ Ｔｅｃｈｎｉｓｃｈｅ Ｈｏｃｈｓｃｈｕｌｅ Ｚｕｅｒｉｃｈ 三官能性架橋剤
JP6415979B2 (ja) 2011-06-03 2018-10-31 スリーエム イノベイティブ プロパティズ カンパニー ヒドラジノ１ｈ−イミダゾキノリン−４−アミン及びこれから調製された複合体
CN103582496B (zh) 2011-06-03 2016-05-11 3M创新有限公司 具有聚乙二醇链段的异双官能连接基以及由其制成的免疫应答调节剂缀合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861869A (en) * 1986-05-29 1989-08-29 Mallinckrodt, Inc. Coupling agents for joining radionuclide metal ions with biologically useful proteins
IL93432A (en) * 1989-02-24 1994-02-27 Johnson Mathey Inc Hydrazines and hydrazides, their conjugates with macromolecules, and such conjugates labeled with metallic ions
US5112953A (en) * 1989-12-29 1992-05-12 Neorx Corporation Radiolabeled proteins for diagnostic or therapeutic use

Also Published As

Publication number Publication date
FI952141A (fi) 1995-05-04
NO305364B1 (no) 1999-05-18
HK1013420A1 (en) 1999-08-27
PT667859E (pt) 2001-02-28
EP0667859B1 (en) 2000-08-23
DK0667859T3 (da) 2000-10-16
KR100295545B1 (ko) 2001-09-17
KR950704256A (ko) 1995-11-17
JPH08502744A (ja) 1996-03-26
HUT72332A (en) 1996-04-29
DE69329293T2 (de) 2000-12-28
EP0667859A1 (en) 1995-08-23
NZ257376A (en) 1996-02-27
CA2148595C (en) 2002-05-21
AU676863B2 (en) 1997-03-27
WO1994010149A1 (en) 1994-05-11
FI952141A0 (fi) 1995-05-04
JP3542597B2 (ja) 2004-07-14
AU5375594A (en) 1994-05-24
ES2150950T3 (es) 2000-12-16
GB9223168D0 (en) 1992-12-16
ATE195730T1 (de) 2000-09-15
CA2148595A1 (en) 1994-05-11
NO951751L (no) 1995-06-12
NO951751D0 (no) 1995-05-04
HU226459B1 (en) 2008-12-29
GR3034883T3 (en) 2001-02-28
US5679778A (en) 1997-10-21
DE69329293D1 (de) 2000-09-28

Similar Documents

Publication Publication Date Title
FI113044B (fi) 2-hydratsinopyridiinijohdannaisia
US5206370A (en) Certain pyridyl hydrazines and hydrazides useful for protein labeling
JP2683080B2 (ja) トリ‐アザ大環状化合物及びそれらの金属錯体
EP0188256A2 (en) Metal radionuclide labeled proteins for diagnosis and therapy
AU2253388A (en) Tetra-aza macrocycles and metal complexes thereof
US5218128A (en) Bifunctional coupling agents and radionuclide labeled compositions prepared therefrom
JP5705434B2 (ja) キレート剤
JP3073997B2 (ja) タンパク質の標識化
JPH08504400A (ja) 放射性薬剤として使用する金属オキシムキレート
Makris et al. Synthesis, characterization, and biological evaluation of new biotinylated 99mTc/Re‐tricarbonyl complexes
Adelstein Harvard-MIT research program in short-lived radiopharmaceuticals. Technical progress report, 1991
NO179585B (no) Fremgangsmåte ved fremstilling av antistoffkonjugater med makrocykliske bifunksjonelle chelaterte komplekser

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: ANORMED INC.

MA Patent expired